Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may amplify the drug's ability to control blood sugar, potentially offering improved outcomes for individuals with insulin resistance. Further research is underway to fully evaluate the lon